Thrombin-Activatable Fibrinolysis Inhibitor (TAFI, Plasma Procarboxypeptidase B, Procarboxypeptidase R, Procarboxypeptidase U)
- 1 March 2001
- journal article
- review article
- Published by Elsevier in Thrombosis Research
- Vol. 101 (5) , 329-354
- https://doi.org/10.1016/s0049-3848(00)00411-4
Abstract
No abstract availableKeywords
This publication has 113 references indexed in Scilit:
- Enzymic characterization of a novel member of the regulatory B-like carboxypeptidase with transcriptional repression function: stimulation of enzymic activity by its target DNABiochemical Journal, 1999
- Purification and Characterization of Human Metallocarboxypeptidase ZBiochemical and Biophysical Research Communications, 1999
- Refolding of potato carboxypeptidase inhibitor by molecular dynamics simulations with disulfide bond constraints a aEdited by A. R. FershtJournal of Molecular Biology, 1998
- TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin ComplexPublished by Elsevier ,1996
- A eukaryotic transcriptional represser with carboxypeptidase activityNature, 1995
- Activation and Characterization of Procarboxypeptidase B from Human PlasmaBiochemistry, 1995
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.Journal of Clinical Investigation, 1993
- An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunitsBiochemical and Biophysical Research Communications, 1989
- C‐terminal lysine residues of fibrinogen fragments essential for binding to plasminogenFEBS Letters, 1985